It develops as a result of decompensation of other diseases of the cardiovascular system, such as hypertension, arrhythmia, cardiomyopathy ... component of the treatment of patients with heart ...

While some new medications have helped advance the treatment of hypertrophic cardiomyopathy, experts say improvements in ...

"This technology will allow us to get the right drug, to the right person, at the right time," says Maynes, Chief of the Department of Anesthesia and Pain Medicine, Associate Chief of Research for ...

A new clinical practice guideline provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes ...

an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is the generic name for AMVUTTRA ®, which is currently approved ...

Hypertrophic cardiomyopathy (HCM ... and the most appropriate investigations for persons suspected of having HCM. Treatment strategies for the disease and its complications are presented briefly.

Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with ...

HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

We look forward to working closely with the EMA with the aim to bring this new treatment option to patients ... test), quality of life (Kansas City Cardiomyopathy Questionnaire), and heart failure ...

An advanced robotic system at The Hospital for Sick Children (SickKids) is changing the way physicians and scientists ...